EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 0.3% of their position (107.00 shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $823.58 — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/16/2025ACC: 0001641172-25-015207
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+107.00
Net shares
Net buyer
$823.58
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
107.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+107.00
Price / share
$7.70
Trade value
$823.58
% of position
0.3%
6/13/2025
38.78K→38.88K
Total
Net shares
+107.00
Net value
$823.58
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2025 | P · Purchase | +107.00 | $7.70 | $823.58 | 0.3% | 38.78K | 38.88K |
| Total | +107.00 | $823.58 | ||||||
Derivative Transactions0
No derivative transactions reported